Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography–electrospray ionization–tandem mass spectrometry-Reference-Cited by-同舟云学术

Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography–electrospray ionization–tandem mass spectrometry

Published:2015-01 Issue: Volume:102 Page:9-16
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Kim Hyo-Ji,Seo Kyung-Ah,Kim Hyun-Mi,Jeong Eun-Sook,Ghim Jong Lyul,Lee Seung Heon^ORCID,Lee Young Min,Kim Dong Hyun^ORCID,Shin Jae-Gook

Funder

Korea Centers for Disease Control and Prevention

National Research Foundation (NRF)

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference21 articles.

1. Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients;Li;Chest,2004

2. Therapeutic drug monitoring in the treatment of tuberculosis;Peloquin;Drugs,2002

3. Towards Universal Access to Diagnosis and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis by 2015;World Health Organization,2011

4. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis;Kim;Am. J. Respir. Crit. Care Med.,2010

5. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis;Kim;Clin. Infect. Dis.,2007

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring in tuberculosis;European Journal of Clinical Pharmacology;2024-09-06

2. Optimisation of analytical methods for tuberculosis drug detection in wastewater: A multinational study;Heliyon;2024-05

3. Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure;International Journal of Antimicrobial Agents;2024-02

4. Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting;Journal of Korean Medical Science;2024

5. Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management;Journal of Pharmaceutical Analysis;2024-01